Drug Development for Cancer and Diabetes
A Path to 2030
-
- $54.99
-
- $54.99
Publisher Description
Key features include:
Details the role of plants for the treatment and management of cancer and diabetes
Discusses the role of phytocompounds as ligands for cancer and diabetic targets
Reviews plants and the potential of phytochemicals as antidiabetic and anticancer drugs
Explores the green biosynthesis of nanoparticles and their treatment efficiency
GENRE
Professional & Technical
RELEASED
2020
August 30
LANGUAGE
EN
English
LENGTH
362
Pages
PUBLISHER
Apple Academic Press
SELLER
Taylor & Francis Group
SIZE
13.2
MB